AI Article Synopsis
- BKV nephritis is a significant cause of kidney transplant dysfunction, and current diagnosis relies on invasive biopsies.
- Researchers analyzed urine samples from various kidney transplant recipients to test if measuring BKV VP1 mRNA could accurately predict BKV nephritis.
- Results showed that BKV VP1 mRNA levels were highly predictive of nephritis with a sensitivity of 93.8% and specificity of 93.9%, suggesting this method could provide a noninvasive alternative for diagnosis.
Article Abstract
Background: Polyoma virus type BK (BKV) nephritis has emerged as an important cause of renal allograft dysfunction and graft failure. Its diagnosis is contingent on the invasive procedure of allograft biopsy. A noninvasive diagnostic test for BKV nephritis could improve clinical outcome.
Methods: We obtained 25 urine specimens from 8 renal allograft recipients with biopsy-confirmed BKV nephritis, 31 samples from 28 recipients in whom BKV nephritis was excluded by allograft biopsy, and 74 specimens from 34 patients with stable allograft function. RNA was isolated from the urinary cells and reverse transcribed to complementary DNA. We designed gene-specific oligonucleotide primers and probes for the measurement of messenger RNA (mRNA) encoding BKV VP1 protein and a constitutively expressed 18S ribosomal RNA (rRNA) by real-time quantitative polymerase chain reaction. We explored the hypothesis that BKV VP1 mRNA levels predict BKV nephritis.
Results: The levels of BKV VP1 mRNA but not the levels of 18S rRNA predicted BKV nephritis. Analysis involving the receiver operating characteristic curve demonstrated that BKV nephritis can be predicted with a sensitivity of 93.8% and a specificity of 93.9% with the use of a cutoff value of 6.5 x 10 BKV VP1 mRNA copy number per nanogram of total RNA ( <0.00001). In the receiver operating characteristic curve analysis, the calculated area under the curve was 0.949 (95% confidence interval, 0.912 to 0.987, <0.00001) for BKV VP1 mRNA levels and 0.562 (95% confidence interval, 0.417 to 0.708, >0.2) for 18S rRNA.
Conclusions: Measurement of BKV VP1 mRNA in urinary cells offers a noninvasive and accurate means of diagnosing BKV nephritis.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1097/00007890-200210150-00016 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
BK Virus Nephropathy After Kidney Transplantation and Its Diagnosis Using Urinary Micro RNA.
Transplant Proc
November 2024
Department of Surgery Nephrology Center, Toranomon Hospital, Tokyo Japan.
BK virus-associated nephritis (BKVAN) is an important cause of graft loss in renal transplant recipients B K viremia occurs in up to 30% of renal transplant recipients. Since the discovery of BKV in 1971, effective prophylaxis and treatment have not been established, and it is not uncommon for a transplant kidney to be lost without cure of BKVAN. BK virus infection is reactivated when cellular immunity is suppressed, which is often during the first year after kidney transplantation when cellular immunity is most suppressed.
View Article and Find Full Text PDFComparison of two RT-qPCR methods targeting BK polyomavirus microRNAs in kidney transplant recipients.
Front Med (Lausanne)
November 2023
Laboratoire de Virologie, Centre Hospitalier Universitaire Amiens-Picardie, Amiens, France.
Background: BK polyomavirus replication leads to progressive tubulointerstitial nephritis and ureteral stenosis, with a considerable risk of subsequent graft failure in kidney transplant recipients. Since specific antiviral therapies are lacking, new tools are required to enhance the biological monitoring of the infection. Viral microRNAs are promising new biomarkers, but the performance of RT-qPCR methods limits the clinical application and the validation of a standard method for quantification.
View Article and Find Full Text PDFThe Importance of 1-Year Protocol Biopsy in the Long-Term Prognosis of Kidney Transplants-5-Years Follow-Up.
Transplant Proc
November 2023
Department of Transplantation Medicine, Nephrology and Internal Medicine, Medical University of Warsaw, Warsaw, Poland.
Article Synopsis
- Protocol biopsies can identify early subclinical issues in kidney transplant patients which may lead to graft dysfunction, but their routine use varies across transplant centers.* -
- In a study of 61 patients, those with mild inflammatory lesions and BK virus nephropathy showed improved long-term outcomes after treatment adjustments following protocol biopsies.* -
- Overall, protocol biopsies appear valuable for early detection of problems in transplants, helping to maintain stable kidney function and potentially preventing graft failure.*
The Tacrolimus Concentration/Dose Ratio Does Not Predict Early Complications After Kidney Transplantation.
Transpl Int
May 2023
Department of Nephrology and Hypertension, University Hospital Schleswig-Holstein, Christian-Albrechts-University, Kiel, Germany.
Early-on post kidney transplantation, there is a high risk of graft rejection and opportunistic viral infections. A low tacrolimus concentration/dose (C/D) ratio as a surrogate marker of fast tacrolimus metabolism has been established for risk stratification 3 months post-transplantation (M3). However, many adverse events occurring earlier might be missed, and stratification at 1 month post-transplantation (M1) has not been investigated.
View Article and Find Full Text PDFBackground: BK virus (BKV)-associated nephropathy (BKVN) is one of the leading causes of renal dysfunction and graft loss in renal transplant recipients. Early monitoring of BKV in urine is crucial to minimize the deleterious effects caused by this virus on preservation of graft function.
Methods: We report a simple, rapid, sensitive loop-mediated isothermal amplification (LAMP) assay using an HFman probe for detecting BKV in urine.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!